Cirrhosis screening

	Cirrhosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cirrhosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Tertiary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case studies
Case #1
Cirrhosis screening On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cirrhosis screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cirrhosis screening
CDC on Cirrhosis screening
Cirrhosis screening in the news
Blogs on Cirrhosis screening
Directions to Hospitals Treating Cirrhosis
Risk calculators and risk factors for Cirrhosis screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]

Overview[edit | edit source]

Screening for hepatocellular carcinoma (HCC) must be done in every cirrhotic patient. It is performed at a frequency of 6-12 months. Screening endoscopy for detection of esophageal varices must be performed at regular intervals in all patients.

Screening[edit | edit source]

Patients with cirrhosis must undergo screening for hepatocellular carcinoma (HCC) every 6-12 months.^[1]^[2]
Screening endoscopy for detection of esophageal varices must be performed:^[3]^[4]
- Within a year in case of compensated cirrhosis
- Within three months in case of complicated cirrhosis

References[edit | edit source]

↑ "Cirrhosis: Diagnosis, Management, and Prevention - American Family Physician".
↑ Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M (2007). "Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?". Am. J. Gastroenterol. 102 (11): 2448–57, quiz 2458. doi:10.1111/j.1572-0241.2007.01395.x. PMID 17617210.
↑ Heidelbaugh JJ, Bruderly M (2006). "Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation". Am Fam Physician. 74 (5): 756–62. PMID 16970019.
↑ Qureshi W, Adler DG, Davila R, Egan J, Hirota W, Leighton J, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO (2005). "ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005". Gastrointest. Endosc. 62 (5): 651–5. doi:10.1016/j.gie.2005.07.031. PMID 16246673.

Template:WS Template:WH

[urlCirrhosis:_Diagnosis,_Management,_and_Prevention_-_American_Family_Physician-1] "Cirrhosis: Diagnosis, Management, and Prevention - American Family Physician".

[pmid17617210-2] Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M (2007). "Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis?". Am. J. Gastroenterol. 102 (11): 2448–57, quiz 2458. doi:10.1111/j.1572-0241.2007.01395.x. PMID 17617210.

[pmid16970019-3] Heidelbaugh JJ, Bruderly M (2006). "Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation". Am Fam Physician. 74 (5): 756–62. PMID 16970019.

[pmid16246673-4] Qureshi W, Adler DG, Davila R, Egan J, Hirota W, Leighton J, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO (2005). "ASGE Guideline: the role of endoscopy in the management of variceal hemorrhage, updated July 2005". Gastrointest. Endosc. 62 (5): 651–5. doi:10.1016/j.gie.2005.07.031. PMID 16246673.

[1]

[2]

[3]

[4]